Assessment of echocardiographic abnormalities in patients with systemic lupus erythematosus: Correlation with levels of antiphospholipid antibodies

Italian Heart Journal

Volumn 1, Issue 7, 2000, Pages 487-492

  Gentile, R ^a   Lagana, B ^a   Tubani, L ^a   Casato, M ^a   Ferri, G M ^a   Fedele, F ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Antiphospholipid antibodies; Cardiac involvement; Systemic lupus erythematosus

Indexed keywords

PHOSPHOLIPID ANTIBODY;

ADOLESCENT; ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOPPLER ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART DISEASE; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; INCIDENCE; MALE; PERICARDIAL EFFUSION; SYSTEMIC LUPUS ERYTHEMATOSUS; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

ADOLESCENT; ADULT; ANTIBODIES, ANTIPHOSPHOLIPID; COMPARATIVE STUDY; ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY, DOPPLER; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART DISEASES; HEART VALVE DISEASES; HUMAN; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGE; MYOCARDIAL CONTRACTION; PERICARDIAL EFFUSION; PROSPECTIVE STUDIES; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0033830205     PISSN: 1129471X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. The heart in systemic lupus erythematosus
2. Cardiovascular manifestations of systemic lupus erythematosus by prospective analysis
3. Cardiovascular involvement in systemic lupus erythematosus
4. An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus
5. The anticardiolipin syndrome
6. A reassessment of the antiphospholipid syndrome
7. Cardiac abnormalities in systemic lupus erythematosus. Association with raised anticardiolipin antibodies
8. A comparison of cardiac valvular involvement in the primary antiphospholipid syndrome versus anticardiolipin-negative systemic lupus erythematosus
9. Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome
10. Prevalence of valvular involvement in systemic lupus erythematosus and association with antiphospholipid syndrome: A matched echocardiographic study
11. Cardiac valve involvement in systemic lupus erythematosus and primary antiphospholipid syndrome: Lack of correlation with antiphospholipid antibodies
12. Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus
13. The 1982 revised criteria for the classification of systemic lupus erythematosus
14. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus
15. Measurement of anti-cardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): Standardization and quantitation of results
16. Antiphospholipid antibodies
17. Evaluation of the anti-cardiolipin antibody test: Report of an international workshop held 4 April 1986
18. The Second International Anti-cardiolipin Standardization Workshop
19. Determination of the calibration equation which achieves best accuracy and precision of the anticardiolipin assay
20. Doppler echocardiography distinguishes between physiologic and pathologic 'silent' mitral regurgitation in patients with rheumatic fever
21. Cardiac valve replacement in systemic lupus erythematosus. A review
22. Clinically significant valvular heart disease in systemic lupus erythematosus
23. The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy
24. Prevalence, morphologic types, and evolution of cardiac valvular diseases in systemic lupus erythematosus
25. High prevalence of significant heart valve lesions in patients with the 'primary' antiphospholipid syndrome
26. Comparison of the primary and secondary antiphospholipid syndrome: A European multicenter study of 114 patients
27. The antiphospholipid syndrome
28. Technetium-99 sestamibi SPECT detects sub-clinical myocardial perfusion abnormalities in patients with systemic lupus erythematosus
29. The catastrophic antiphospholipid syndrome
30. Cross reaction between antibodies to oxidized low-density lipoprotein and to cardiolipin in systemic lupus erythematosus
31. Antibodies to oxidised LDL
32. Lipoprotein oxidation and autoantibodies: A new path in atherothrombosis
33. Echocardiographic findings at myocarditis
34. Autoantibodies to phospholipid-binding plasma proteins: A new view of lupus anticoagulants and other antiphospholipid autoantibodies
35. Influence of the antiphospholipid syndrome in the survival of patients with systemic lupus erythematosus